Intrastriatal grafts from multiple donors do not result in a proportional increase in survival of dopamine neurons in nonhuman primates.

[1]  A. Granholm,et al.  Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum , 1997, Experimental Brain Research.

[2]  A. Björklund,et al.  Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. , 1996, Neuroscience.

[3]  E. Mufson,et al.  Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies , 1996, The Journal of comparative neurology.

[4]  B. Hoffer,et al.  GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats , 1996, Cell and Tissue Research.

[5]  C. Olanow,et al.  Fetal nigral transplantation as a therapy for Parkinson's disease , 1996, Trends in Neurosciences.

[6]  P R Sanberg,et al.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. , 1995, The New England journal of medicine.

[7]  D. Choi-Lundberg,et al.  Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. , 1995, Brain research. Developmental brain research.

[8]  H. Phillips,et al.  TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons , 1994, Neuron.

[9]  L. Costantini,et al.  Enhanced Efficacy of Nigral-Striatal Cotransplants in Bilaterally Dopamine-Depleted Rats: An Anatomical and Behavioral Analysis , 1994, Experimental Neurology.

[10]  G. Nikkhah,et al.  Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model , 1994, Brain Research.

[11]  L. Olson,et al.  Glial Cell Line-Derived Neurotrophic Factor Is Expressed in the Developing but Not Adult Striatum and Stimulates Developing Dopamine Neurons in Vivo , 1993, Experimental Neurology.

[12]  R. Roth,et al.  Fetal Dopamine Cell Survival after Transplantation Is Dramatically Improved at a Critical Donor Gestational Age in Nonhuman Primates , 1993, Experimental Neurology.

[13]  J. Ahlskog.  Cerebral transplantation for Parkinson's disease: current progress and future prospects. , 1993, Mayo Clinic proceedings.

[14]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[15]  J. Sladek,et al.  Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery , 1990, Experimental Neurology.

[16]  A. Davies.  The emerging generality of the neurotrophic hypothesis , 1988, Trends in Neurosciences.

[17]  A. Prochiantz,et al.  Release of dopamine from dissociated mesencephalic dopaminergic neurons in primary cultures in absence or presence of striatal target cells , 1980, Brain Research.

[18]  B. Berger,et al.  In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Abercrombie.  Estimation of nuclear population from microtome sections , 1946, The Anatomical record.

[20]  C. Ricordi.  Methods in cell transplantation , 1995 .

[21]  F. Gage,et al.  Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells. , 1986, Brain research.